Saint-Priez en Jarez, France Clinical Trials

A listing of Saint-Priez en Jarez, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence

Stereo-Re-Pro aims to provide further evidence of Stereotactic Body Radiotherapy (SBRT) as a supplementary non-invasive curative treatment for local recurrence following radiotherapy. The objective of the first part of the trial (Phase I) is to select the recommended dose for salvage SBRT (either 5 x 6 Gy, 6 x 6 …

Institut de Canc rologie Lucien Neuwirth
 (0.5 away) Contact site
  • 0 views
  • 25 Jan, 2021
  • +14 other locations
Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)

This is an open-label, multicentre study to characterize the safety and efficacy of the human anti-CD38 antibody MOR202 in adult subjects with in Anti-PLA2R Antibody Positive Membranous Nephropathy (newly diagnosed/relapsed/refractory)

immunosuppression
glomerular filtration rate
ACTH
tacrolimus
ace inhibitor
CHU de Grenoble - H pital Albert Michallon
 (66.1 away) Contact site
  • 23 views
  • 31 Mar, 2021
  • +48 other locations
CPX-351 in Higher Risk Myelodysplastic Syndromes

Study of the efficacy of CPX-351 treatment in patients with higher risk myelodysplastic syndromes : as first line treatment or after hypomethylating agents failure

chronic myelomonocytic leukemia
conjugated bilirubin
lenalidomide
cytarabine
direct bilirubin
Institut de Canc rologie Lucien Neuwirth - H matologie Clinique - Th rapie Cellulaire
 (0.5 away) Contact site
  • 0 views
  • 23 Jul, 2021
  • +15 other locations
Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy

Phase I of the study is designed to determine the recommended phase II dose (RP2D) for tazemetostat in patients treated with 8 cycles of R-CHOP 21. Phase II of the study is designed to determine the safety and the efficacy of tazemetostat in DLBCL and FL patients : DLBCL : …

indolent lymphoma
neutrophil count
vincristine
gilbert's syndrome
doxorubicin
CHU Lyon Sud
 (26.6 away) Contact site
  • 10 views
  • 28 Jul, 2021
  • +30 other locations